Novo Integrated Sciences Inc (NVOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
(Values in U.S. thousands)
| 08-2024 | 05-2024 | 02-2024 | 11-2023 | 08-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,129 | -21,143 | -7,406 | -4,661 | -13,269 |
| Depreciation Amortization | 8,836 | 6,793 | 3,331 | 1,648 | 7,060 |
| Accounts receivable | -453 | -798 | -691 | -1,168 | -597 |
| Accounts payable and accrued liabilities | -267 | 408 | -1,333 | -99 | 1,771 |
| Other Working Capital | -1,202 | -558 | -1,886 | -1,283 | 461 |
| Other Operating Activity | 4,145 | 10,774 | 4,120 | 3,410 | 2,332 |
| Operating Cash Flow | $-5,070 | $-4,524 | $-3,866 | $-2,152 | $-2,243 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5 | -2 | N/A | N/A | -49 |
| Investing Cash Flow | $-5 | $-2 | $N/A | $0 | $-49 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 8,650 | 8,649 | 3,314 | 3,314 | 1,509 |
| Debt Repayment | -7 | -7 | -6 | -3 | -9 |
| Common Stock Issued | 240 | 240 | 240 | 240 | 2,328 |
| Other Financing Activity | -3,892 | -3,763 | -249 | -256 | -3,064 |
| Financing Cash Flow | $4,991 | $5,119 | $3,300 | $3,296 | $764 |
| Exchange Rate Effect | 512 | 530 | 802 | 80 | -234 |
| Beginning Cash Position | 416 | 416 | 416 | 416 | 2,179 |
| End Cash Position | 845 | 1,540 | 652 | 1,640 | 416 |
| Net Cash Flow | $428 | $1,123 | $235 | $1,224 | $-1,762 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,070 | -4,524 | -3,866 | -2,152 | -2,243 |
| Capital Expenditure | -5 | -2 | N/A | N/A | -49 |
| Free Cash Flow | -5,075 | -4,526 | -3,866 | -2,152 | -2,293 |